148 related articles for article (PubMed ID: 12426209)
1. Growth factors enhance interleukin-1 beta-induced persistent activation of nuclear factor-kappa B in rat vascular smooth muscle cells.
Jiang B; Xu S; Brecher P; Cohen RA
Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1811-6. PubMed ID: 12426209
[TBL] [Abstract][Full Text] [Related]
2. Persistent activation of nuclear factor-kappaB by interleukin-1beta and subsequent inducible NO synthase expression requires extracellular signal-regulated kinase.
Jiang B; Brecher P; Cohen RA
Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1915-20. PubMed ID: 11742864
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-kappaB activation in vascular smooth muscle cells.
Doi M; Shichiri M; Katsuyama K; Marumo F; Hirata Y
Hypertens Res; 2000 Nov; 23(6):659-67. PubMed ID: 11131279
[TBL] [Abstract][Full Text] [Related]
4. Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression.
Jiang B; Xu S; Hou X; Pimentel DR; Brecher P; Cohen RA
J Biol Chem; 2004 Jan; 279(2):1323-9. PubMed ID: 14581482
[TBL] [Abstract][Full Text] [Related]
5. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Hirata Y
J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells.
Doi M; Shichiri M; Katsuyama K; Ishimaru S; Hirata Y
Atherosclerosis; 2002 Jan; 160(1):123-32. PubMed ID: 11755929
[TBL] [Abstract][Full Text] [Related]
7. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
[TBL] [Abstract][Full Text] [Related]
8. Catalase potentiates interleukin-1beta-induced expression of nitric oxide synthase in rat vascular smooth muscle cells.
Guikema BJ; Ginnan R; Singer HA; Jourd'heuil D
Free Radic Biol Med; 2005 Mar; 38(5):597-605. PubMed ID: 15683716
[TBL] [Abstract][Full Text] [Related]
9. Vascular neuronal NO synthase is selectively upregulated by platelet-derived growth factor: involvement of the MEK/ERK pathway.
Nakata S; Tsutsui M; Shimokawa H; Tamura M; Tasaki H; Morishita T; Suda O; Ueno S; Toyohira Y; Nakashima Y; Yanagihara N
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2502-8. PubMed ID: 16224055
[TBL] [Abstract][Full Text] [Related]
10. Role of nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways in IL-1 beta-mediated induction of alpha-PDGF receptor expression in rat pulmonary myofibroblasts.
Lindroos PM; Rice AB; Wang YZ; Bonner JC
J Immunol; 1998 Oct; 161(7):3464-8. PubMed ID: 9759865
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II differentially regulates interleukin-1-beta-inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK.
Jiang B; Xu S; Hou X; Pimentel DR; Cohen RA
J Biol Chem; 2004 May; 279(19):20363-8. PubMed ID: 15001568
[TBL] [Abstract][Full Text] [Related]
12. beta-very low density lipoprotein enhances inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells.
Takahashi M; Takahashi S; Shimpo M; Naito A; Ogata Y; Kobayashi E; Ikeda U; Shimada K
Atherosclerosis; 2002 Jun; 162(2):307-13. PubMed ID: 11996950
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding epidermal growth factor-like growth factor inhibits cytokine-induced NF-kappa B activation and nitric oxide production via activation of the phosphatidylinositol 3-kinase pathway.
Mehta VB; Besner GE
J Immunol; 2005 Aug; 175(3):1911-8. PubMed ID: 16034135
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation.
Hattori Y; Hattori S; Kasai K
Eur J Pharmacol; 2003 Nov; 481(2-3):153-8. PubMed ID: 14642780
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide potentiates interleukin-1beta-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells.
Jeong SO; Pae HO; Oh GS; Jeong GS; Lee BS; Lee S; Kim du Y; Rhew HY; Lee KM; Chung HT
Biochem Biophys Res Commun; 2006 Jul; 345(3):938-44. PubMed ID: 16707097
[TBL] [Abstract][Full Text] [Related]
16. Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation.
Yan ZQ; Sirsjö A; Bochaton-Piallat ML; Gabbiani G; Hansson GK
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2854-62. PubMed ID: 10591661
[TBL] [Abstract][Full Text] [Related]
17. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta.
Hecker M; Preiss C; Schini-Kerth VB
Br J Pharmacol; 1997 Mar; 120(6):1067-74. PubMed ID: 9134219
[TBL] [Abstract][Full Text] [Related]
18. Effects of barbiturates on the expression of the inducible nitric oxide synthase in vascular smooth muscle.
Kessler P; Kronemann N; Hecker M; Busse R; Schini-Kerth VB
J Cardiovasc Pharmacol; 1997 Dec; 30(6):802-10. PubMed ID: 9436821
[TBL] [Abstract][Full Text] [Related]
19. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1796-802. PubMed ID: 9812920
[TBL] [Abstract][Full Text] [Related]
20. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
